Aiping Pharm Inc received FDA approval for ANDA 078499, a regulatory milestone that enhances the company's market position and signals a potential expansion into the competitive generic sector. This approval establishes Aiping Pharm Inc's capability in the U.S. market and may impact supply chains generally.